Effect of nebivolol on renal nitric oxide availability and tubular function in patients with essential hypertension

AIMS: Nebivolol is a selective β(1)-receptor antagonist with vasodilating properties. In patients with essential hypertension, we tested the hypothesis that nebivolol increases systemic and renal nitric oxide (NO) availability using L-N(G)-monomethyl arginine (L-NMMA) as an inhibitor of NO productio...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Br J Clin Pharmacol
Autors principals: Mose, Frank H, Jensen, Janni M, Therwani, Safa, Mortensen, Jesper, Hansen, Annebirthe B, Bech, Jesper N, Pedersen, Erling B
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Ltd 2015
Matèries:
Clinical Trials
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4574828/
https://ncbi.nlm.nih.gov/pubmed/25778445
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.12627
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars